Profits for Stryker, a medical device manufacturing giant, have taken a 2.3 percent cut year-over-year when projections had predicted they’d be up by 14.1 percent. This is likely due to the number of lawsuits regarding the company’s Rejuvenate or ABG II modular metal-on-metal neck hip stems. Information about the earnings came about a month after Stryker announced that Howmedica Osteonics, its subsidiary, had reached a settlement with patients who required revision surgery to correct problems with their new Rejuvenate or ABG II metal-on-metal hips. The metal-on-metal hip implant designs, made by a number of medical device manufacturers such as Wright Medical, DePuy Orthopaedics and its parent company Johnson & Johnson; Smith & Nephew, and Zimmer Biomet ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.